Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jenny Shannon"'
Autor:
Jenny Shannon, Moubassira Kagone, Baltazar Candrinho, Sylvanus Otikwu, Chantal Ingabire, Adama Gansane, Samy Pooda, Fofana Aboubacar, Fatou Ouattara, Binete Savaio, Celestino Joanguete, Lucio Sixpence, Hannah Koenker, Perpetua Uhomoibhi, Okefu Oyale Okoko, Onoja Ali, Dele Babarinde, Janet Ogundairo, Ayorinde Samuel Lemah, Aimable Mbituyumuremyi, Joseph H. Singirankabo, Nami Kawakyu, Federica Guglielmo, Christen Fornadel, Kyra Arnett, Joe Wagman, Christelle Gogue, Kenzie Tynuv, Peder Digre, Julia Mwesigwa, Molly Robertson
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-16 (2024)
Abstract Background Universal coverage with insecticide-treated nets (ITNs) is important for malaria control and elimination. The emergence and intensification of insecticide resistance threatens progress made through the deployment of these interven
Externí odkaz:
https://doaj.org/article/e77412a388044a16abf0cd220a9ef43f
Autor:
Marjan M. Naeini, Felicity Newell, Lauren G. Aoude, Vanessa F. Bonazzi, Kalpana Patel, Guy Lampe, Lambros T. Koufariotis, Vanessa Lakis, Venkateswar Addala, Olga Kondrashova, Rebecca L. Johnston, Sowmya Sharma, Sandra Brosda, Oliver Holmes, Conrad Leonard, Scott Wood, Qinying Xu, Janine Thomas, Euan Walpole, G. Tao Mai, Stephen P. Ackland, Jarad Martin, Matthew Burge, Robert Finch, Christos S. Karapetis, Jenny Shannon, Louise Nott, Robert Bohmer, Kate Wilson, Elizabeth Barnes, John R. Zalcberg, B. Mark Smithers, John Simes, Timothy Price, Val Gebski, Katia Nones, David I. Watson, John V. Pearson, Andrew P. Barbour, Nicola Waddell
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Oesophageal adenocarcinoma is a poor prognosis cancer and the molecular features underpinning response to treatment remain unclear. We investigate whole genome, transcriptomic and methylation data from 115 oesophageal adenocarcinoma patients
Externí odkaz:
https://doaj.org/article/10a795104a0f4275aaca1728299e2389
Autor:
Adama Gansané, Baltazar Candrinho, Aimable Mbituyumuremyi, Perpetua Uhomoibhi, Sagnon NFalé, Audu Bala Mohammed, Wamdaogo Moussa Guelbeogo, Antoine Sanou, David Kangoye, Siaka Debe, Moubassira Kagone, Emmanuel Hakizimana, Aline Uwimana, Albert Tuyishime, Chantal M. Ingabire, Joseph H. Singirankabo, Hannah Koenker, Dulcisaria Marrenjo, Ana Paula Abilio, Crizologo Salvador, Binete Savaio, Okefu Oyale Okoko, Ibrahim Maikore, Emmanuel Obi, Samson Taiwo Awolola, Adedapo Adeogun, Dele Babarinde, Onoja Ali, Federica Guglielmo, Joshua Yukich, Sara Scates, Ellie Sherrard-Smith, Thomas Churcher, Christen Fornadel, Jenny Shannon, Nami Kawakyu, Emily Beylerian, Peder Digre, Kenzie Tynuv, Christelle Gogue, Julia Mwesigwa, Joseph Wagman, Monsuru Adeleke, Ande Taiwo Adeolu, Molly Robertson
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-20 (2022)
Abstract Background Vector control tools have contributed significantly to a reduction in malaria burden since 2000, primarily through insecticidal-treated bed nets (ITNs) and indoor residual spraying. In the face of increasing insecticide resistance
Externí odkaz:
https://doaj.org/article/5287e2bdb5c84be18981b3b829f533e7
Autor:
Jeanne Tie, Yuxuan Wang, Joshua Cohen, Lu Li, Wei Hong, Michael Christie, Hui Li Wong, Suzanne Kosmider, Rachel Wong, Benjamin Thomson, Julian Choi, Adrian Fox, Kathryn Field, Matthew Burge, Jenny Shannon, Dusan Kotasek, Niall C Tebbutt, Christos Karapetis, Craig Underhill, Andrew Haydon, Joy Schaeffer, Janine Ptak, Cristian Tomasetti, Nicholas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Peter Gibbs
Publikováno v:
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
BackgroundIn patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy continues to be debated. Previous studies have shown that circulating tumor DNA (ctDNA) analysis, as a marker of minimal res
Externí odkaz:
https://doaj.org/article/5fefae544f494349b57c0bd567ac52e2
Autor:
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, Harpreet Wasan, David Malka, Lars Henrik Jensen, Takuji Okusaka, Jennifer J. Knox, Dorothea Wagner, David Cunningham, Jenny Shannon, David Goldstein, Markus Moehler, Tanios Bekaii-Saab, Juan W. Valle
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Outcomes in younger (
Externí odkaz:
https://doaj.org/article/1f47fd39a5a24fdd807afd04722451a9
Autor:
Marjan Naeini, Felicity Newell, Lauren G Aoude, Vanessa F Bonazzi, Kalpana Patel, Guy Lampe, Lambros T Koufariotis, Vanessa Lakis, Venkateswar Addala, Olga Kondrashova, Rebecca L Johnston, Sowmya Sharma, Sandra Brosda, Oliver Holmes, Conrad Leonard, Scott Wood, Qinying Xu, Janine Thomas, Euan Walpole, G Tao Mai, Stephen P Ackland, Jarad Martin, Matthew Burge, Robert Finch, Christos S Karapetis, Jenny Shannon, Louise Nott, Robert Bohmer, Kate Wilson, Elizabeth Barnes, John R Zalcberg, B Mark Smithers, John Simes, Timothy Price, Val Gebski, Katia Nones, David I Watson, John V Pearson, Andrew P Barbour, Nicola Waddell
Publikováno v:
Diseases of the Esophagus. 35
The incidence of oesophageal adenocarcinoma (OAC) is rising in Western countries, with a 5-year overall survival (OS) rate of 14%. Curative treatment based on oesophagectomy is only suitable for ~50% of patients due to late-stage diagnosis. While the
Autor:
Cristian Tomasetti, Dusan Kotasek, Bert Vogelstein, Craig Underhill, Suzanne Kosmider, Julian Choi, Peter Gibbs, Adrian Fox, Wei Hong, Yuxuan Wang, Hui-Li Wong, Jeanne Tie, Christos S Karapetis, Niall C. Tebbutt, Joy Schaeffer, Benjamin N. J. Thomson, Lu Li, Andrew Haydon, Matthew Burge, Joshua D. Cohen, Jenny Shannon, Janine Ptak, Michael Christie, Kenneth W. Kinzler, Kathryn M. Field, Nicholas Papadopoulos, Rachel Wong
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
Background In patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy continues to be debated. Previous studies have shown that circulating tumor DNA (ctDNA) analysis, as a marker of minimal re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffca5f1804285e3c3daa386a9dc7debe
Autor:
Peter Fox, Craig Gedye, Jenny Shannon, Ian N. Olver, Karen Briscoe, Stephen Begbie, John Simes, Stephen Della-Fiorentina, Stephen Clarke, Martin R. Stockler, Nicholas Lintzeris, E Abdi, Morteza Aghmesheh, Peter Grimison, C. Hahn, Anna Walsh, Antony Mersiades, Adrienne Kirby, Annette Tognela, Y. Cheung, Rachael L. Morton, Paul S. Haber, Iain S. McGregor
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 31(11)
Background This multicentre, randomised, double-blinded, placebo-controlled, phase II/III trial aimed to evaluate an oral THC:CBD (tetrahydrocannabinol:cannabidiol) cannabis extract for prevention of refractory chemotherapy-induced nausea and vomitin
Autor:
David Cunningham, David Malka, John Bridgewater, Dieter Koeberle, David Goldstein, Lars Henrik Jensen, Markus Moehler, Juan W. Valle, Thierry André, Jenny Shannon, Tanios Bekaii-Saab, Harpreet Wasan, Takuji Okusaka, Mairéad G McNamara, Anna Dorothea Wagner, Andre Lopes, Jennifer J. Knox
Publikováno v:
Mcnamara, M, Lopes, A, Wasan, H, Malka, D, Goldstein, D, Shannon, J, Okusaka, T, Knox, J J, Wagner, A D, Andre, T, Cunningham, D, Moehler, M, Jensen, L H, Koeberle, D, Bekaii-Saab, T, Bridgewater, J & Valle, J 2020, ' Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer ', Journal of Hepatology, vol. 73, no. 5, pp. 1109-1117 . https://doi.org/10.1016/j.jhep.2020.05.014
McNamara, M G, Lopes, A, Wasan, H, Malka, D, Goldstein, D, Shannon, J, Okusaka, T, Knox, J J, Wagner, A D, André, T, Cunningham, D, Moehler, M, Jensen, L H, Koeberle, D, Bekaii-Saab, T, Bridgewater, J & Valle, J W 2020, ' Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer ', Journal of Hepatology, vol. 73, no. 5, pp. 1109-1117 . https://doi.org/10.1016/j.jhep.2020.05.014
McNamara, M G, Lopes, A, Wasan, H, Malka, D, Goldstein, D, Shannon, J, Okusaka, T, Knox, J J, Wagner, A D, André, T, Cunningham, D, Moehler, M, Jensen, L H, Koeberle, D, Bekaii-Saab, T, Bridgewater, J & Valle, J W 2020, ' Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer ', Journal of Hepatology, vol. 73, no. 5, pp. 1109-1117 . https://doi.org/10.1016/j.jhep.2020.05.014
BACKGROUND & AIMS: Whether all patients with advanced biliary tract cancer (aBTC) should be included in prospective trials, irrespective of the anatomic site of origin, is debated. Herein, we aimed to assess the survival impact of anatomic site of or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1b324211c649093f7c4ee1926fbea50
https://pure.manchester.ac.uk/ws/files/164319248/2020_05_07_Clean_Landmark_Survival_in_BTC.docx
https://pure.manchester.ac.uk/ws/files/164319248/2020_05_07_Clean_Landmark_Survival_in_BTC.docx
Autor:
Peter Gibbs, Volker Heinemann, Navesh K. Sharma, Julien Taieb, Jens Ricke, Marc Peeters, Michael Findlay, Bridget Robinson, Christopher Jackson, Andrew Strickland, Val Gebski, Mark Van Buskirk, Huaqing Zhao, Guy van Hazel, Michael Brown, Matthew Burge, Giuseppe Cardaci, Stephen Clarke, Paul Eliadis, Tom Ferguson, Vinod Ganju, Philip James, Chris Karapetis, Winston Liauw, Gavin Marx, Marco Matos, Louise Nott, Nick Pavlakis, Alex Powell, Timothy Price, David Ransom, Eva Segelov, Jenny Shannon, Nimit Singhal, Euan Walpole, Michel Craninx, Thierry Delaunoit, Amélie Deleporte, Michel Ferrante, Karen Geboes, Alain Hendlisz, Koen Hendrickx, Marc De Man, Els Monsaert, Veerle Moons, Marc Polus, Eveline Boucher, Jacques Balosso, Patrick Chevallier, Samy Louafi, Marc Pracht, Christine Rebischung, Denis Smith, Eric Terrebonne, Harald-Robert Bruch, Gerald Gehbauer, Thomas Helmberger, Yon-Dschun Ko, Hendrik Kröning, Frank Lammert, Arnd Nusch, Stefan Pluntke, Karsten Ridwelski, Jorge Riera-Knorrenschild, Hanno Riess, Jorge Ramon Riera, Tilmann Sauerbruch, Klemens Scheidhauer, Oliver Stötzer, Klaus Tatsch, Ursula Vehling-Kaiser, Thomas Vogl, Alex Beny, Ravit Geva, Einat Shacham-Shmueli, Salomon Stemmer, Thomas Tichler, Ido Wolf, Bruna Angelelli, Andrea Martoni, Michael P.N. Findlay, Richard Isaacs, Anne O’Donnell, David Perez, Bridget A. Robinson, Javier Rodríguez, Ruth Vera-Garcia, Pradip Amin, Daniel Bloomgarden, James Bui, James Carlisle, Seungjean Chai, Yi-Jen Chen, Michael Chuong, Andrew Coveler, Francis Facchini, Gary Frenette, Jacob Frick, Michael Garofalo, Benjamin George, Michael Gordon, Seza Gulec, James Hannigan, Matthew Holtzman, Andreas Kaubisch, Adeel Kaiser, Todd Kooy, Steven Limentani, Jeffrey Margolis, Robert Martin, Howard Ozer, Siddarth Padia, William Rilling, Michael Savin, Elyse Schneiderman, Grant Seeger, Navesh Sharma, Stephen Shibata, Randall Smith, Eric Wang, Samuel Whiting, Morteza Aghmesheh, Mathew Burge, Prasad Cooray, Kynan Feeney, Lionel Lim, Madhu Singh, Craig Underhill, Amelie Deleporte, Aurelie Durand, Sandrine Faivre, Aurelie Ferru, Pascal Hammel, Christoph Bremer, Maike De Wit, Hubert Ayala, Norman Heching, Adi Shani, Cristina Granetto, Gianluca Masi, Stefania Mosconi, Gianmauro Numico, Antonio Trogu, Yeul Hong Kim, Han Sae-Won, Chris Jackson, Anne O'Donnell, Maria Fragoso, Iain Tan, Ana Ruiz Casado, Jin Tung Liang, Jin Hwang Liu, Steven Ades, Miklos Auber, Patrick Boland, Charles Bowers, Martin Crain, Kyran Dowling, Renuka Iyer, Lynn Ratner, Federico Sanchez, Patricia Stoltzfus, Mark Westcott
Publikováno v:
Clinical colorectal cancer
The primary tumor side is emerging as a prognostic factor for patients with liver metastatic colorectal cancer (mCRC). In a combined analysis of data from 2 randomized studies, the addition of selective internal radiation therapy to first-line chemot